Efficacy and Safety of the Heat Shock Protein 90 Inhibitor RGRN-305 in Hidradenitis Suppurativa

Authors:

Abstract
Hidradenitis suppurativa is a chronic, immune-mediated, inflammatory skin disease that has a profound negative influence on the patients’ quality of life, affecting approximately 1% of the population.1 The disease often presents during adolescence with painful inflammatory nodules and abscesses that may form tunnels and result in extensive scarring, manifesting predominantly in axillary, inguinal, inframammary, and anogenital regions, but other regions may also be affected.2 Although the exact pathogenic mechanisms remain partly unknown, aberrant inflammation plays a crucial role in the pathogenesis.3 The cutaneous changes in hidradenitis suppurativa seem to start around hair follicles and involve activation of cells of both the innate and adaptive immune system. Furthermore, pivotal roles for a number of proinflammatory cytokines and signaling pathways, including tumor necrosis factor (TNF), interleukin (IL)-1β, IL-17, and IL-36, have been described.4

This publication has 28 references indexed in Scilit: